{"id":"W4385074099","doi":"10.1016/j.jtct.2023.07.013","title":"Racial and Socioeconomic Disparities in Long-Term Outcomes in ≥1 Year Allogeneic Hematopoietic Cell Transplantation Survivors: A CIBMTR Analysis","year":2023,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"National Institute of Allergy and Infectious Diseases; Office of Naval Research; Pharmacyclics; Sanofi Genzyme; Takeda Oncology; Genentech; Health Resources and Services Administration; MorphoSys; Adaptive Biotechnologies; Astellas Pharma; bluebird bio; Kiadis Pharma; Omeros Corporation; Pfizer; Incyte; Medac; Jazz Pharmaceuticals; StemCyte; Bristol-Myers Squibb; CSL Behring; Karyopharm Therapeutics; CareDx; Actinium Pharmaceuticals; Daiichi Sankyo Europe; National Cancer Institute; Gilead Sciences; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Amgen; Accenture; Sanofi; GlaxoSmithKline; Seagen; Astellas Pharma US","keywords":"Medicine; Transplantation; Population; Demography; Socioeconomic status; Hematopoietic stem cell transplantation; Ethnic group; Hematopoietic cell; Cohort; Gerontology; Internal medicine; Haematopoiesis; Stem cell; Environmental health","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001015119,0.0003568646,0.0004162982,0.001216656,0.0008357132,0.0008124282,0.0006861888,0.000566916,0.003242577],"category_scores_gemma":[0.002121198,0.0002877561,0.001628106,0.002272232,0.0002799258,0.0006474855,0.001314705,0.001115969,0.000274849],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005261593,"about_ca_system_score_gemma":0.001062822,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02874463,"about_ca_topic_score_gemma":0.02985619,"domain_scores_codex":[0.9990325,0.0001989657,0.00009022905,0.0001701102,0.0001042475,0.0004040054],"domain_scores_gemma":[0.9988099,0.0001446676,0.0004841732,0.0001231073,0.0001269719,0.0003112175],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001898936,0.00008882659,0.997821,0.00001059219,0.000273511,0.00003044723,0.00009088901,0.00004608131,0.00008681677,0.0000827523,0.000228896,0.001050337],"study_design_scores_gemma":[0.00001124171,0.00007928148,0.9986113,0.0000102144,0.0001694313,0.00005240331,0.0005643243,0.0001723976,0.0000276882,0.00005463037,0.0002413158,0.000005821145],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.998179,0.0002355522,0.00008134049,0.00007989216,0.0000109857,0.000008261145,0.0009363327,0.000002332006,0.0004664292],"genre_scores_gemma":[0.9988355,0.0001150699,0.00004953939,0.00004956926,0.00001340377,0.00001481007,0.0007546554,0.000003028067,0.0001642599],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02874463,"threshold_uncertainty_score":0.05715466,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01762113482383612,"score_gpt":0.2841672491203169,"score_spread":0.2665461142964808,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}